Supportive Cancer Care
An Introduction to Supportive Cancer Care
Supportive care is an important area within cancer, aiming to improve the quality of life of patients by treating or preventing symptoms and side effects caused by treatment, whilst providing psychological and social support. Along with advancing treatments to address side effects such as nausea and vomiting, research into complementary and alternative therapies such as yoga and mindfulness is in progress.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Supportive Cancer Care Content
Supportive Care in Cancer During COVID-19
On June 25, 2020, a panel of MASCC experts led a virtual discussion on how the COVID-19 pandemic impacts cancer patients and how healthcare professionals can support them during the pandemic. Topics included the next steps after the crisis is resolved; precautions to take in the months ahead with a potential second wave; and the impact on […]
Andreas Charalambous, ESMO 2019 – EONS Safety Manifesto
Andreas Charalambous, President of the European Oncology Nursing Society (EONS), joined us at ESMO 2019 to highlight the work EONS have been doing around safety and specifically their Safety Manifesto. Questions 1. How can cancer nurses reduce the risk of harm to patients? (0:05) 2. What general precautions should cancer nurses take in terms of […]
Cancer Nursing Deserves Better Recognition
European Oncology & Haematology, 2019:15(1):19–20 DOI: https://doi.org/10.17925/EOH.2019.15.1.19
Cancer is a growing problem that demands the best from all sectors of the global health workforce.1 Cancer nurses make up the largest proportion of this workforce and, as well as being responsible for direct care delivery, also aim to address the unmet needs of patients and carers, such as the management of side-effects. Nurses care […]
10 reasons to attend EONS12 @ ESMO 2019
Click here to read more Click here to register
András Illés, ESMO 2018 – A New Biosimilar for the Treatment of Chemotherapy-induced Neutropenia
In an expert interview at ESMO 2018, Dr András Illés discusses the current research behind RGB-02, a biosimilar pegfilgrastim for the treatment of chemotherapy-induced neutropenia. Biosimilars are subjected to rigorous clinical trials to ensure equivalence to the originator drug in terms of safety, efficacy, and pharmacokinetic and pharmacodynamic profiles. So far two sets of results […]
Daniel A Vorobiof, ESMO 2018 – Prevalence of Cancer-related Fatigue
Dr Daniel A Vorobiof, Chief Medical Officer at Belong.Life, New York, NY, US, provides an overview of the findings of his study on the impact of cancer-related fatigue on patients and caregivers, and options of management and prevention. Belong.Life is the world’s largest professional social network for cancer patients and caregivers. Questions: 1. Could you […]
Eva C Winkler, ESMO 2018 – Financial Toxicity in German Cancer Patients: How Does a Chronic Disease Impact the Economic Situation?
There is a lack of consistency regarding what constitutes as financial toxicity and how to measure it in patients who have cancer. At this year’s ESMO, we met up with Dr Eva Winkler to learn more about this under-researched topic. As patients with cancer live longer, their financial burden increases. Dr Winkler and her team […]
Daniel Kelly, ESMO 2018 – The European Oncology Nurses Society’s RECaN Project
The European Oncology Nurses Society (EONS) is currently undertaking its RECaN project which is aimed at increasing the recognition of cancer nursing across Europe. At this year’s ESMO congress, EONS presented the first two phases of the RECaN project. Past President of EONS, Prof Daniel Kelly, is passionate about this project and what it can […]
Lena Sharp, ESMO 2018 – The European Oncology Nursing Society
Almost 60% of European countries do not recognise cancer nursing as a defined specialty, and therefore do not provide targeted educational programmes. This has resulted in vast differences in the education levels and roles of cancer nurses across European countries. The CARE strategy, developed by the European Oncology Nursing Society (EONS), is made up of […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!